These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 2046758)
1. Food and Drug Administration. Tempest over polio vaccine. Anderson C Nature; 1991 Jun; 351(6327):510. PubMed ID: 2046758 [No Abstract] [Full Text] [Related]
2. Decision analysis in planning for a polio outbreak in the United States. Jenkins PC; Modlin JF Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814 [TBL] [Abstract][Full Text] [Related]
3. Cost analysis of post-polio certification immunization policies. Sangrujee N; Cáceres VM; Cochi SL Bull World Health Organ; 2004 Jan; 82(1):9-15. PubMed ID: 15106295 [TBL] [Abstract][Full Text] [Related]
4. Many questions remain in wake of court ruling on FDA's polio vaccine licensing procedures. Marwick C JAMA; 1991 Jul; 266(3):318-9. PubMed ID: 2056634 [No Abstract] [Full Text] [Related]
5. Re: Laboratory tests for live attenuated poliovirus vaccine. Subhash C. Arya; Biologicals, Volume 26, pp. 245-246, 1998. Milstien JB; Zaffran M; Wood DJ; Griffiths E Biologicals; 1999 Sep; 27(3):277-8. PubMed ID: 10652184 [No Abstract] [Full Text] [Related]
6. Oral polio vaccine and human cancer: a reassessment of SV40 as a contaminant based upon legal documents. Kops SP Anticancer Res; 2000; 20(6C):4745-9. PubMed ID: 11205211 [TBL] [Abstract][Full Text] [Related]
7. Medical costs and the drug industry. Schwartz H Wall St J Midwest Ed; 1980 Apr; 60(132):22. PubMed ID: 10245744 [No Abstract] [Full Text] [Related]
8. Retrospective cost-effectiveness analyses for polio vaccination in the United States. Thompson KM; Tebbens RJ Risk Anal; 2006 Dec; 26(6):1423-40. PubMed ID: 17184390 [TBL] [Abstract][Full Text] [Related]
9. Medical costs and the drug industry. Schwartz H Med Times; 1981 Mar; 109(3):21s-24s, 28s. PubMed ID: 7207081 [No Abstract] [Full Text] [Related]
10. Polio endgame. Wanted: drug for a disappearing disease. Enserink M Science; 2004 Mar; 303(5666):1971. PubMed ID: 15044783 [No Abstract] [Full Text] [Related]
11. Rat immunogenicity assay of inactivated poliovirus. Bevilacqua JM; Young L; Chiu SW; Sparkes JD; Kreeftenberg JG Dev Biol Stand; 1996; 86():121-7. PubMed ID: 8785941 [TBL] [Abstract][Full Text] [Related]
12. Dr. Goddard and the PMA. Rev Allergy; 1969 Mar; 23(3):161-3. PubMed ID: 5786222 [No Abstract] [Full Text] [Related]
13. Wherever HIV originated, polio vaccine is safe now. Wong KW Nature; 2000 Jan; 403(6766):130. PubMed ID: 10646575 [No Abstract] [Full Text] [Related]
16. The cost-effectiveness of alternative polio immunization policies in South Africa. Griffiths UK; Botham L; Schoub BD Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096 [TBL] [Abstract][Full Text] [Related]
17. Rising costs hold up drug discovery. Miller HI Nature; 1998 Oct; 395(6705):835. PubMed ID: 9804407 [No Abstract] [Full Text] [Related]
18. What does R&D really cost? Huff B GMHC Treat Issues; 2001; 15(7-8):1-7. PubMed ID: 11548507 [No Abstract] [Full Text] [Related]
19. Who pays what in drug development. Love J Nature; 1999 Jan; 397(6716):202. PubMed ID: 9930689 [No Abstract] [Full Text] [Related]
20. [Problems connected with the drug provision in the United States]. Sloot HA Pharm Weekbl; 1969 Jul; 104(30):914-23. PubMed ID: 5800761 [No Abstract] [Full Text] [Related] [Next] [New Search]